| Miriam Maite Sevilla Saez-benito, MD | |
|
1525 River Oaks Rd W, New Orleans, LA 70123-2199 | |
| (504) 818-1392 | |
| Not Available |
| Full Name | Miriam Maite Sevilla Saez-benito |
|---|---|
| Gender | Female |
| Speciality | Psychiatry & Neurology - Child & Adolescent Psychiatry |
| Location | 1525 River Oaks Rd W, New Orleans, Louisiana |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003134917 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0804X | Psychiatry & Neurology - Child & Adolescent Psychiatry | 330443 (Louisiana) | Primary |
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 30443 (Alabama) | Secondary |
| Entity Name | Altapointe Health Systems Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1518095413 PECOS PAC ID: 1052224052 Enrollment ID: O20040206000701 |
News Archive
Tyrogenex, a privately held company focused on the development of targeted therapeutics for cancer and ophthalmology, today announced data from its phase 1 open-label study of orally-administered X-82 in patients for wet age-related macular degeneration (AMD).
Cytheris SA and the Cancer Immunotherapy Trials Network, a new initiative in immunotherapy funded by the National Cancer Institute with its Central Operations and Statistical Center headquartered at Fred Hutchinson Cancer Research Center, Seattle, Washington, today announced the selection of recombinant human interleukin-7, the investigational multifunctional cytokine under development by Cytheris, as one of the first immunotherapeutic agents proposed for initial clinical trials at network institutions.
Liquidia Technologies, Inc. announced today that it has entered into a collaboration and license agreement with Abbott to develop PRINT nanoparticles for the delivery of siRNA-based therapeutics. Liquidia's PRINT technology offers the ability to fabricate nanoparticles of precisely defined size, shape, surface chemistry, and composition, which offers the potential to develop safer and more effective therapies.
Like wrenches made of Legos, SWI/SNF chromatin remodeling complexes tighten or loosen DNA in our cells to control how genes are turned on and made into proteins.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Miriam Maite Sevilla Saez-benito, MD 5750a Southland Dr, Mobile, AL 36693-3316 Ph: (251) 450-2211 | Miriam Maite Sevilla Saez-benito, MD 1525 River Oaks Rd W, New Orleans, LA 70123-2199 Ph: (504) 818-1392 |
News Archive
Tyrogenex, a privately held company focused on the development of targeted therapeutics for cancer and ophthalmology, today announced data from its phase 1 open-label study of orally-administered X-82 in patients for wet age-related macular degeneration (AMD).
Cytheris SA and the Cancer Immunotherapy Trials Network, a new initiative in immunotherapy funded by the National Cancer Institute with its Central Operations and Statistical Center headquartered at Fred Hutchinson Cancer Research Center, Seattle, Washington, today announced the selection of recombinant human interleukin-7, the investigational multifunctional cytokine under development by Cytheris, as one of the first immunotherapeutic agents proposed for initial clinical trials at network institutions.
Liquidia Technologies, Inc. announced today that it has entered into a collaboration and license agreement with Abbott to develop PRINT nanoparticles for the delivery of siRNA-based therapeutics. Liquidia's PRINT technology offers the ability to fabricate nanoparticles of precisely defined size, shape, surface chemistry, and composition, which offers the potential to develop safer and more effective therapies.
Like wrenches made of Legos, SWI/SNF chromatin remodeling complexes tighten or loosen DNA in our cells to control how genes are turned on and made into proteins.
› Verified 8 days ago
Korak Sarkar, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 2820 Napoleon Ave Ste 810, New Orleans, LA 70115 Phone: 504-894-2395 | |
Dr. Maurice David Gelder, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 5323 Coliseum Street, New Orleans, LA 70115 Phone: 504-899-4160 | |
Abdul Hafeez Khan, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 719 Elysian Fields Ave, New Orleans, LA 70117 Phone: 504-942-8101 Fax: 504-942-8242 | |
Dr. Lucido Luciano Ponce Mejia, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 2020 Gravier St Fl 7, New Orleans, LA 70112 Phone: 504-568-6120 Fax: 504-568-6127 | |
Jennifer Velander, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1542 Tulane Avenue, 2nd Floor, New Orleans, LA 70112 Phone: 504-568-6004 | |
Dr. Joshua Sanderson, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 1750 St. Charles Ave., Suite 609, New Orleans, LA 70130 Phone: 504-232-1087 |